Research Updates on a Phase III Clinical Trial of Anbenitamab (KN026) Presented at ESMO Congress 2025 LBA Oral Presentation Session
SUZHOU, China, Oct. 18, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and...
Asia Smart Innovation Awards 2025 Winners Announced Hong Kong Takes Silver and Bronze in Lifestyle and Culture Category Thailand Wins Inaugural Grand Award
HONG KONG, Oct. 18, 2025 /PRNewswire/ -- The Hong Kong Wireless Technology Industry Association (WTIA) held the Asia Smart Innovation Awards 2025 Presentation Ceremony at Cordis Hong Kong on 16 October 2025. Organized by WTIA and sponsored by the...
The 14th MINA International Smartphone Film Festival is co-presented by SmallRig, a global leader in innovative imaging solutions
MELBOURNE, Australia, Oct. 17, 2025 /PRNewswire/ -- As smartphone imaging technology continues to advance and mobile filmmaking grows into a global creative movement, SmallRig — a leading global provider of imaging solutions — will co-presented the...
Wired Magazine Founding Editor Kevin Kelly Visits Rokid Headquarters, Exploring the Future of AR and AI
HANGZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Kevin Kelly, founding executive editor of Wired magazine, visited Rokid headquarters in Hangzhou for a deep dialogue with Misa Zhu, Founder & CEO of Rokid. They engaged in a forward-looking...
Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC
CHENGDU, China, Oct. 17, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate (ADC) trastuzumab botidotin...
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in identifying select difficult-to-map variants SAN DIEGO, Oct. 17, 2025 /PRNewswire/ --...
Compal Showcases Comprehensive Data Center Solutions at 2025 OCP Global Summit; Unveils SGX30-2 High-Performance AI Server Built with NVIDIA HGX™ B300
SAN JOSE, Calif., Oct. 17, 2025 /PRNewswire/ -- Global data centers are facing new challenges driven by AI – greater compute demand, larger working sets, and more stringent energy efficiency requirements. At this year's OCP Global Summit, Compal...
Unixell Biotech reported a case study of UX-DA001, an iPSC-derived autologous cell therapy for Parkinson Diseases at MDS Congress 2025
SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's disease (PD) and other neurological disorders, announced positive 6-month follow-up data from...
Renowned Artist Yuan Xikun Honors Heroic Narcotics Detection Dog with Sculpture for International Day Against Drug Abuse and Illicit Trafficking
BEIJING, June 25, 2025 /PRNewswire/ -- Acclaimed Chinese artist and sculptor, inaugural United Nations "Artistic Master for the Environment" Yuan Xikun, renowned for his environmental advocacy and animal-themed art, has unveiled a commemorative...
Innovent announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China were Orally Presented at ADA 85th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...